Literature DB >> 1392887

Fluoxetine treatment of severe premenstrual syndrome.

D B Menkes1, E Taghavi, P A Mason, G F Spears, R C Howard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392887      PMCID: PMC1883028          DOI: 10.1136/bmj.305.6849.346

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Premenstrual syndrome.

Authors:  R L Reid
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

2.  Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change.

Authors:  J Bancroft; A Cook; D Davidson; J Bennie; G Goodwin
Journal:  Psychol Med       Date:  1991-05       Impact factor: 7.723

Review 3.  The treatment of late luteal phase dysphoric disorder.

Authors:  S Steinberg
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

Review 4.  The relationship of menstrually related mood disorders to psychiatric disorders.

Authors:  P P Roy-Byrne; M C Hoban; D R Rubinow
Journal:  Clin Obstet Gynecol       Date:  1987-06       Impact factor: 2.190

5.  The clinical diagnosis and classification of premenstrual changes.

Authors:  U Halbreich; J Endicott; J Lesser
Journal:  Can J Psychiatry       Date:  1985-11       Impact factor: 4.356

  5 in total
  14 in total

Review 1.  The pathophysiologic background for current treatments of premenstrual syndromes.

Authors:  Uriel Halbreich
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 2.  Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorder.

Authors:  Ellen W Freeman
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 3.  Depression and myocardial infarction. Implications for medical prognosis and options for treatment.

Authors:  T J Cleophas
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

Review 4.  Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder.

Authors:  Ellen W Freeman
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 5.  Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.

Authors:  M Steiner
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

6.  Sleep and Women's Health.

Authors:  Sara Nowakowski; Jessica Meers; Erin Heimbach
Journal:  Sleep Med Res       Date:  2013

Review 7.  Cognitive Behavioral Therapy for Insomnia and Women's Health: Sex as a Biological Variable.

Authors:  Sara Nowakowski; Jessica M Meers
Journal:  Sleep Med Clin       Date:  2019-03-27

Review 8.  The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.

Authors:  B L Parry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

9.  Tryptophan in the treatment of late luteal phase dysphoric disorder: a pilot study.

Authors:  S Steinberg; L Annable; S N Young; M C Bélanger
Journal:  J Psychiatry Neurosci       Date:  1994-03       Impact factor: 6.186

Review 10.  Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.

Authors:  Ellen W Freeman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.